Product category:
Proteomics
News Release from: AnaSpec | Subject: Peptide products for cancer research
Edited by the Laboratorytalk Editorial
Team on 15 November 2006
Melanoma epitopes used in tumour
regression study
Several antigens expressed in melanoma cells and recognised by T cells have been identified and used in developing immunisation approaches for tumour regression
Melanoma, a malignant tumor that arises in melanocytes, is the most deadly of all skin cancers Although it accounts for only 4% of all skin cancer cases, melanoma is the leading cause of skin cancer deaths
Several antigens expressed in melanoma cells and recognised by T cells have been identified and used in developing immunisation approaches for tumour regression.
These include: Mart-1/Melan-A, gp100, Tyrosinase, p15, TRP-1 and beta-catenin2.
AnaSpec, a provider of integrated proteomics solutions, offers a broad collection of peptide products for cancer research, including an extensive listing of melanoma immunodominant epitopes and their analogues.
• AnaSpec: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
